Eiko Lifesciences Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 8.01 | 7.96 | 7.02 |
| Operating Expense | 6.93 | 6.58 | 6.46 |
| Net Profit | 0.69 | 0.90 | 0.28 |
| Net Profit Margin | 8.61 | 11.31 | 3.99 |
| Earning Per Share | 0.50 | 0.69 | 0.24 |
| EBIDTA | 1.06 | 1.35 | 0.52 |
| Effective Tax Rate | 18.69 | 18.84 | 12.50 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 8.01 |
| Operating Expense | 6.93 |
| Net Profit | 0.69 |
| Net Profit Margin | 8.61 |
| Earning Per Share | 0.50 |
| EBIDTA | 1.06 |
| Effective Tax Rate | 18.69 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 32.49 | 27.93 | 18.32 |
| Operating Expenses Annual | 30.78 | 26.32 | 17.37 |
| Operating Profit Annual | 3.07 | 1.79 | 1.81 |
| Interest Annual | 0.13 | 0.14 | 0.15 |
| Depreciation | 0.63 | 0.66 | 0.63 |
| Net Profit Annual | 1.74 | 0.75 | 0.77 |
| Tax Annual | 0.58 | 0.23 | 0.26 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 32.49 |
| Operating Expenses Annual | 30.78 |
| Operating Profit Annual | 3.07 |
| Interest Annual | 0.13 |
| Depreciation | 0.63 |
| Net Profit Annual | 1.74 |
| Tax Annual | 0.58 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 13.35 | 0.61 | 0.22 |
| Cash Flow from Operations | 2.05 | -7.08 | 4.22 |
| Cash Flow from Investing | -9.85 | -0.55 | 0.87 |
| Cash Flow from Financing | 5.97 | 20.36 | -4.70 |
| Cash Flow at the End | 11.51 | 13.35 | 0.61 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 13.35 |
| Cash Flow from Operations | 2.05 |
| Cash Flow from Investing | -9.85 |
| Cash Flow from Financing | 5.97 |
| Cash Flow at the End | 11.51 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 8.37 | 6.44 | 9.93 |
| PBIT Margin (%) | 6.43 | 4.08 | 6.50 |
| PBT Margin (%) | -43.06 | -22.88 | -34.11 |
| Net PROFIT Margin (%) | 5.36 | 2.69 | 4.20 |
| Return On Networth / Equity (%) | 2.75 | 1.87 | 2.65 |
| Return On Networth /Employed (%) | 3.84 | 2.82 | 3.79 |
| Return On Assets (%) | 3.21 | 1.88 | 2.44 |
| Total Debt / Equity (X) | 0.02 | TBA | 0.08 |
| Asset Turnover Ratio (%) | 0.60 | 0.70 | 0.58 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 8.37 |
| PBIT Margin (%) | 6.43 |
| PBT Margin (%) | -43.06 |
| Net PROFIT Margin (%) | 5.36 |
| Return On Networth / Equity (%) | 2.75 |
| Return On Networth /Employed (%) | 3.84 |
| Return On Assets (%) | 3.21 |
| Total Debt / Equity (X) | 0.02 |
| Asset Turnover Ratio (%) | 0.60 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 14.26 | 13.57 | 13.88 |
| Total Current Assets Annual | 28.42 | 30.93 | 9.30 |
| Non Current Assets Annual | 31.96 | 21.81 | 21.74 |
| Total Shareholders Funds Annual | 56.42 | 50.68 | 29.42 |
| Total Assets Annual | 60.37 | 52.74 | 31.04 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 14.26 |
| Total Current Assets Annual | 28.42 |
| Non Current Assets Annual | 31.96 |
| Total Shareholders Funds Annual | 56.42 |
| Total Assets Annual | 60.37 |
EPS (INR)
Expected
0.66
Reported
0.66
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 5.26%
Sep 2024
EPS beaten by 0.00%
